AN2 Therapeutics is based in Menlo Park, California. It has raised $161M in total funding. Latest round: IPO.
AN2 Therapeutics funding overview
AN2 Therapeutics is based in Menlo Park, California. AN2 Therapeutics has raised $161M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is an IPO announced in March 2022. The round record for AN2 Therapeutics runs through 2022; nothing later has been disclosed.
AN2 Therapeutics at a glance
Total raised
$161M
Latest round
IPO
Latest round date
March 2022
Headquarters
Menlo Park, California
Frequently asked about AN2 Therapeutics funding
How much has AN2 Therapeutics raised?
AN2 Therapeutics has raised $161M in total disclosed funding across the rounds on record.
Who has invested in AN2 Therapeutics?
No investors are named on the public record for AN2 Therapeutics yet.
What was the latest AN2 Therapeutics funding round?
The most recent disclosed round is an IPO, announced in March 2022.
Where is AN2 Therapeutics based?
AN2 Therapeutics is based in Menlo Park, California.
When did AN2 Therapeutics last raise?
The last disclosed AN2 Therapeutics round closed in March 2022 at IPO.
We update the AN2 Therapeutics record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Menlo Park and their backers are listed below.
